Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.89
Delayed Data
As of Feb 16
 +0.04 / +0.82%
Today’s Change
4.01
Today|||52-Week Range
8.38
+5.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-111.5M-123.1M-161.1M--
 
 
 
 
Depreciation306.0K596.0K1.0M--
 
 
 
 
Total Other Cash Flow27.0M30.6M81.3M--
 
 
 
 
Funds From Operations-83.6M-91.9M-78.7M--
 
 
 
 
Funds From/For Other Operating Expenses-2.6M35.6M7.9M--
 
 
 
 
Net Cash Flow - Operating Activities-81.0M-127.5M-86.6M--
 
 
 
 
 
InvestingIncrease In Investments-49.8M0.000.00--
 
 
Decrease In Investments38.3M11.5M0.00--
 
 
 
Capital Expenditures-1.5M-2.8M-2.1M--
 
 
 
 
Net Cash Flow Investing-13.0M8.7M-2.1M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.00125.0M0.00--
 
 
Long Term Debt Reduction0.00--0.00----
Net Proceeds Stock Sale112.6M119.7M198.0K--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00--0.00----
Other Uses - Financing0.0015.0K0.00--
 
 
Net Cash Flow - Financing112.6M244.7M198.0K--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash18.6M126.0M-88.5M0.00